Leith, C P <br/><br/>
Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group study.  [electronic resource] 

 -  Blood  May 1997 
 - 3323-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0006-4971 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ATP Binding Cassette Transporter, Subfamily B, Member 1--biosynthesis<br/>Age Factors<br/>Aged<br/>Aged, 80 and over<br/>Antigens, CD--biosynthesis<br/>Antigens, CD34--biosynthesis<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Chromosome Aberrations<br/>Chromosome Disorders<br/>Cytarabine--administration & dosage<br/>Daunorubicin--administration & dosage<br/>Double-Blind Method<br/>Drug Resistance, Multiple--genetics<br/>Female<br/>Granulocyte Colony-Stimulating Factor--therapeutic use<br/>Humans<br/>Leukemia, Myeloid, Acute--drug therapy<br/>Leukemia, Promyelocytic, Acute--drug therapy<br/>Male<br/>Middle Aged<br/>Neoplasms, Second Primary--drug therapy<br/>Recombinant Proteins--therapeutic use